You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Granzyme B

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Renal Cancer, Urethral Cancer Trial in San Francisco (Copper-64 labeled Granzyme B (64Cu-GRIP B), Positron

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Copper-64 labeled Granzyme B (64Cu-GRIP B)
  • Positron Emission Tomography (PET)
  • San Francisco, California
    University of California, San Francisco
Jun 7, 2023

Pancreatic Cancer Trial in Baltimore (Tislelizumab, SX-682)

Not yet recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    Johns Hopkins SKCCC
Jan 23, 2023

Relapsed and/or Refractory B-cell Lymphoma Trial in Stanford, Baltimore, Houston (Cyclophosphamide, Fludarabine, KITE-363)

Recruiting
  • Relapsed and/or Refractory B-cell Lymphoma
  • Stanford, California
  • +2 more
Aug 16, 2022

Crosstalk Between Mucosal-Associated Invariant T Cells and Gut

Recruiting
  • Type1diabetes
  • MAIT cells analysis
  • +4 more
  • Antony, France
  • +1 more
Aug 2, 2022

COVID-19 Trial in Toyoake (EXG-5003, Placebo)

Completed
  • COVID-19
  • EXG-5003
  • Placebo
  • Toyoake, Aichi, Japan
    Fujita Health University Hospital
Jan 24, 2023

Relapsed or Refractory Large B-cell Lymphoma Trial in Nashville (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • Relapsed or Refractory Large B-cell Lymphoma
  • Axicabtagene Ciloleucel
  • +3 more
  • (no location specified)
Jul 13, 2022

Therapy After Kidney Transplantation

Recruiting
  • Transplantation Infection
  • Kidney Diseases
    • Odense, DK, Denmark
      Odense University Hospital
    Nov 5, 2021

    Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)

    Completed
    • Head and Neck Squamous Cell Carcinoma
    • Shreveport, Louisiana
    • +3 more
    Oct 3, 2023

    Diagnostic Agent Adverse Reaction, Radiation Exposure Trial in New Haven (18F-LY3950321, PET Scan)

    Recruiting
    • Diagnostic Agent Adverse Reaction
    • Radiation Exposure
    • New Haven, Connecticut
      Invicro, LLC
    Mar 20, 2023

    Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

    Active, not recruiting
    • Fallopian Tube Clear Cell Adenocarcinoma
    • +22 more
    • Laboratory Biomarker Analysis
    • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
    • Rochester, Minnesota
      Mayo Clinic
    Oct 7, 2022

    Prostate Cancer Trial in Baltimore (Enoblituzumab, Standard of Care)

    Not yet recruiting
    • Prostate Cancer
    • Baltimore, Maryland
      Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Aug 25, 2023

    Glioblastoma, Glioma, Malignant Trial in Durham (MT-201-GBM monocyte vaccine)

    Not yet recruiting
    • Glioblastoma
    • Glioma, Malignant
    • MT-201-GBM monocyte vaccine
    • Durham, North Carolina
      The Preston Robert Tisch Brain Tumor Center at Duke University M
    May 25, 2022

    Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)

    Recruiting
    • Multiple Myeloma
    • Plasma Cell Leukemia
    • Human BCMA targeted CAR-NK cells injection
    • Shanghai, Shanghai, China
      Shanghai Changzheng Hospital
    Sep 13, 2023

    Solid Tumor Trial in United States (drug, combination product, biological)

    Recruiting
    • Solid Tumor
    • Pembrolizumab
    • +2 more
    • Sacramento, California
    • +6 more
    Jan 3, 2023

    HIV, Healthy Trial in West Haven (Active Delta-9-THC)

    Recruiting
    • HIV Infections
    • Healthy
    • Active Delta-9-THC
    • West Haven, Connecticut
      VA Connecticut Healthcare System
    Aug 2, 2022

    Melanoma Trial in Boulogne-Billancourt (venous puncture, tumoral biopsy)

    Recruiting
    • Melanoma
    • venous puncture
    • tumoral biopsy
    • Boulogne-Billancourt, France
      Dermato-oncology department, Ambroise Paré hospital, APHP
    Feb 9, 2022

    Malignant Solid Tumor Trial in Shanghai (Infusion of iNKT cells)

    Completed
    • Malignant Solid Tumor
    • Infusion of iNKT cells
    • Shanghai, China
      Shanghai Public Health Clinical Center, Fudan University
    May 6, 2022

    Head and Neck Squamous Cell Carcinoma, Selenium, Sodium Selenite Trial in Keelung (Zelnite®, Placebo)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +2 more
    • Zelnite®
    • Placebo
    • Keelung, Taiwan
      Chang Gung Memorial Hospital
    Jul 8, 2022

    Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

    Recruiting
    • Clinical Stage I Cutaneous Melanoma AJCC v8
    • +8 more
    • Ipilimumab
    • +4 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Apr 28, 2022

    Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Stage IB3 Cervical Cancer FIGO 2018, Stage II

    Recruiting
    • Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified
    • +13 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 31, 2022

    Multiple Myeloma Trial in Beijing, Guangzhou, Shanghai (TQB2934 injection)

    Not yet recruiting
    • Multiple Myeloma
    • TQB2934 injection
    • Beijing, Beijing, China
    • +2 more
    Dec 8, 2022

    Oral Cavity SCC Trial in Charleston (Nivolumab)

    Completed
    • Oral Cavity SCC
    • Charleston, South Carolina
      Medical University of South Carolina
    Dec 10, 2021

    COPD Greek Patients Based on Standard Clinical Practice.

    Not yet recruiting
    • Copd
    • COPD Exacerbation
      • (no location specified)
      Jun 22, 2022

      Breast Tumors Trial in Guangzhou (procedure, drug, biological)

      Recruiting
      • Breast Neoplasms
      • Surgery for harvesting tumor-draining lymph nodes
      • +6 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital, Sun Yat-sen University
      Nov 2, 2023

      Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Houston

      Active, not recruiting
      • Metastatic Colorectal Carcinoma
      • +4 more
      • Cetuximab
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 4, 2022